QIAGEN and Servier Unite to Develop Companion Diagnostic for Acute Myeloid Leukemia Therapy Drug
QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced it has entered into a strategic partnership with Servier, a global pharmaceutical group, to develop a companion diagnostic test for TIBSOVO®,